Early prostate-specific antigen changes and clinical outcome after 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer - Gafita, A; Heck, MM; Rauscher, I (Journal of Nuclear Medicine, 2020)